We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+24.59%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.9B
AUM Growth
+$12.2B
(+25%)
Cap. Flow
+$2B
Cap. Flow
% of AUM
3.34%
Top 10 Holdings %
Top 10 Hldgs %
21.63%
Holding
3,213
New
281
Increased
1,628
Reduced
1,147
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$134M |
| 2 |
Microsoft
MSFT
|
+$119M |
| 3 |
Apple
AAPL
|
+$87.6M |
| 4 |
AbbVie
ABBV
|
+$61.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$54.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$92.9M |
| 2 |
RTN
Raytheon Company
RTN
|
+$71.6M |
| 3 |
CY
Cypress Semiconductor
CY
|
+$23.6M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$12.9M |
| 5 |
Domino's
DPZ
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.43% |
| 2 | Healthcare | 14.28% |
| 3 | Financials | 13.11% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Communication Services | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXTN
2326
DELISTED
Exterran Corporation
EXTN
| $518K | ﹤0.01% |
96,088
-9,437
| -9% | -$53.5K |
|
|
BRG
2327
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $516K | ﹤0.01% |
63,808
+28,650
| +81% | +$190K |
|
2328
Citizens
CIA
$192M
| $513K | ﹤0.01% |
85,679
-5,550
| -6% | -$31.9K |
|
2329
Puma Biotechnology
PBYI
$454M
| $512K | ﹤0.01% |
49,071
+7,300
| +17% | +$75.6K |
|
|
JCAP
2330
DELISTED
Jernigan Capital, Inc.
JCAP
| $509K | ﹤0.01% |
37,198
-1,337
| -3% | -$17.2K |
|
2331
Passage Bio
PASG
$14.1M
| $508K | ﹤0.01% |
+930
| New | +$418K |
|
2332
Precigen
PGEN
$2.59B
| $508K | ﹤0.01% |
101,871
-10,050
| -9% | -$34.2K |
|
2333
Replimune Group
REPL
$1.01B
| $508K | ﹤0.01% |
20,432
+5,009
| +32% | +$88.6K |
|
2334
Mercer International
MERC
$39.8M
| $507K | ﹤0.01% |
62,166
-11,376
| -15% | -$95K |
|
|
CHL
2335
DELISTED
China Mobile Limited
CHL
| $507K | ﹤0.01% |
+15,078
| New | +$558K |
|
2336
Bally's
BALY
$658M
| $505K | ﹤0.01% |
22,671
+224
| +1% | +$3.95K |
|
2337
Expro Ltd
XPRO
$1.91B
| $503K | ﹤0.01% |
37,582
+11,537
| +44% | +$155K |
|
|
BSTC
2338
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $503K | ﹤0.01% |
8,212
+578
| +8% | +$33.4K |
|
2339
AMC Entertainment Holdings
AMC
$2.31B
| $501K | ﹤0.01% |
11,670
+1,842
| +19% | +$80.5K |
|
2340
Syndax Pharmaceuticals
SNDX
$1.82B
| $500K | ﹤0.01% |
33,744
+10,270
| +44% | +$156K |
|
2341
Select Water Solutions
WTTR
$2.61B
| $500K | ﹤0.01% |
102,106
+4,081
| +4% | +$18.7K |
|
2342
Rayonier Advanced Materials
RYAM
$610M
| $498K | ﹤0.01% |
177,152
-3,816
| -2% | -$7.32K |
|
|
LAND
2343
Gladstone Land Corp
LAND
$360M
| $494K | ﹤0.01% |
31,157
-7,386
| -19% | -$103K |
|
|
CDMO
2344
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $494K | ﹤0.01% |
75,172
+3,888
| +5% | +$21.7K |
|
2345
Gates Industrial Corporation Ltd.
GTES
$7.15B
| $490K | ﹤0.01% |
47,667
-7,407
| -13% | -$67.2K |
|
|
QEP
2346
DELISTED
QEP RESOURCES, INC.
QEP
| $489K | ﹤0.01% |
379,136
-462,088
| -55% | -$431K |
|
2347
UFP Technologies
UFPT
$2.43B
| $488K | ﹤0.01% |
11,074
+279
| +3% | +$11.9K |
|
2348
Byline Bancorp
BY
$1.76B
| $487K | ﹤0.01% |
37,171
+3,995
| +12% | +$45.7K |
|
2349
Modine Manufacturing
MOD
$10.4B
| $486K | ﹤0.01% |
88,099
+940
| +1% | +$4.32K |
|
2350
Amerant Bancorp
AMTB
$1.13B
| $485K | ﹤0.01% |
32,223
+5,028
| +18% | +$67.8K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2020 Portfolio in Review
As of Q2 2020, RhumbLine Advisers held 3,213 positions worth $59.9B, up 25% from $47.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers deployed $2B of net new capital in Q2 2020, opening 281 new positions and adding to 1,628 existing holdings. Its largest new stake was Otis Worldwide: 701,378 shares worth $39.9M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $12.9M trimmed.
- RhumbLine Advisers's largest Q2 2020 buy was Otis Worldwide: 701,378 shares worth $39.9M.
- RhumbLine Advisers added most to Amazon in Q2 2020, an estimated $134M increase.
- RhumbLine Advisers's biggest Q2 2020 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $12.9M.
- RhumbLine Advisers fully exited Allergan plc in Q2 2020, selling an estimated $92.9M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $59.9B portfolio in Q2 2020.
- RhumbLine Advisers opened 281 new positions and closed 147 in Q2 2020.
- RhumbLine Advisers's portfolio value rose 25% quarter-over-quarter to $59.9B.
Based on RhumbLine Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.